Moritz Kircher, MD, PhD
Chairman, Department of Imaging, Dana-Farber Cancer Institute
Dr. Kircher assumed the role as Chairman of the Department Imaging of the Dana-Farber Cancer Institute, as well as directorship of DFCI's Lurie Family Imaging Center and Molecular Cancer Imaging Facility in 2018. He also serves as Chief of Oncoradiology at Brigham Health.
Prior to joining DFCI, Dr. Kircher was an Associate Professor and Attending in the Body Imaging Service, Associate Vice Chair for Research, and Laboratory Head at Memorial Sloan Kettering Cancer Center.
His research focuses on the early detection and high-precision imaging of neoplasms using next-generation multimodal nanoparticle imaging agents based on Raman, MRI, PET, and Optoacoustic imaging technologies. He is one of 6 elected Young Leaders of the "International Society for Strategic Studies in Radiology" (IS3R), served as founding Chair of the "Molecular Imaging in Nanotechnology and Theranostics (MINT)" Interest Group of the World Molecular Imaging Society, and is Editor-in-Chief of the journal Nanotheranostics.
Dr. Kircher conducted his Medical School and doctoral thesis studies at the Humboldt University (Charité) in Berlin, and his habilitation thesis in Raman imaging at the Technical University Munich. After an Internship in Surgery he completed a Radiology Residency at Beth Israel Deaconess Medical Center, postdocs with Prof. Ralph Weissleder at MGH and Prof. Sam Gambhir at Stanford in Molecular Imaging, and a clinical Body MRI Fellowship at Stanford.